Distal Motor Latency in Amyotrophic Lateral Sclerosis: A Robust and Reliable Prognostic Marker

Area of Science:

• Neurology
• Electrophysiology
• Clinical Diagnostics

Background:

• Amyotrophic Lateral Sclerosis (ALS) diagnosis relies on electrophysiological tests.
• Distal Motor Latency (DML) is a standard electrophysiological measure.
• DML's potential as an ALS prognostic marker requires further investigation.

Purpose of the Study:

• To evaluate Distal Motor Latency (DML) as a prognostic marker in Amyotrophic Lateral Sclerosis (ALS).
• To assess the correlation between DML and disease progression/outcomes in ALS patients.

Main Methods:

• A longitudinal study involving 34 ALS patients (17 with normal DML, 17 with prolonged DML).
• Electrophysiological tests measured DML in four standard nerves.
• ALS Functional Rating Scale-Revised (ALSFRS-R) assessed disease severity.
• 6-month follow-up monitored endpoints like death or advanced disease (ALSFRS-R <20).

Main Results:

• ALS patients with prolonged DML showed significantly reduced ALSFRS-R at 6 months (p<0.025).
• Prolonged DML was associated with higher odds (p<0.012, OR=20.718) of poor outcomes.
• Multivariate analysis identified prolonged DML (B=1.412, p<0.031, HR=4.104) and lower baseline ALSFRS-R as predictors of poor prognosis.

Conclusions:

• Prolonged DML is a significant indicator of poor prognosis in ALS patients.
• Patients with prolonged DML experience faster functional decline and disease progression.
• DML serves as a robust prognostic marker for ALS, aiding in personalized management plans.